The dietary or essential fatty acids linoleate and alpha-linolenate play extremely important roles in mammalian physiology. As they cannot be synthesized by mammals, the biosynthesis of all C-20, C-22 and C-24 polyunsaturated fatty acids depends on the availability of essential fatty acids in the diet, primarily from plant sources. A large group of bioactive, oxygenated C-18, C-20 and C-22 fatty acids, collectively known as eicosanoids, are derived from n-3 and n-6 PUFAs. The oxygenated products of polyunsaturated fatty acids, from endogenous and exogenous sources, have potent and wide-ranging effects on many physiological processes in humans including cell proliferation, immune responses, inflammation, renal function, reproduction, and cardiovascular homeostasis. Subtle changes in the regio- and stereochemistry of these compounds can also substantially alter their biological properties. A clear molecular understanding of the chemistry leading to stereochemically unique oxygenated products and how these products are converted into the bioactive target molecules is lacking. The primary focus of this renewal application is on elucidating, by X-ray crystallography and mutagenesis, (a) the structural mechanisms for the recognition and binding of polyunsaturated fatty acids, (b) how the regio- and stereochemistry of bis- or monooxygenation are controlled, and (c) how regio- and stereochemistry affect the further metabolism of the oxygenated polyunsaturated fatty acids. Three classes of enzymes in the metabolism of polyunsaturated fatty acids and their oxygenated products are being studied: sheep and human prostaglandin synthase, rat prostacyclin synthase, and 3 related enzymes of the oxylipin metabolic pathways in plants. These enzymes utilize heme to activate the substrates and are integral membrane proteins. In the previous grant period, the crystal structures of native prostaglandin synthase-1 with bound arachidonic acid and other fatty acids were determined, overexpression systems for recombinant prostaglandin synthases-1 and -2 were developed for crystallographic studies, and over 50 mutants of prostaglandin synthases-1 and -2 were engineered for structural analysis. Thus, the structural details of bis- or monooxygenation reactions can be studied. Overexpression of rat prostacyclin synthase and divinylether synthase also make crystallographic studies on these two membrane-bound P450 enzymes tractable.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL056773-08
Application #
6747636
Study Section
Molecular and Cellular Biophysics Study Section (BBCA)
Program Officer
Goldman, Stephen
Project Start
1996-07-01
Project End
2006-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
8
Fiscal Year
2004
Total Cost
$299,000
Indirect Cost
Name
Michigan State University
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
193247145
City
East Lansing
State
MI
Country
United States
Zip Code
48824
Qin, Ling; Mills, Denise A; Hiser, Carrie et al. (2007) Crystallographic location and mutational analysis of Zn and Cd inhibitory sites and role of lipidic carboxylates in rescuing proton path mutants in cytochrome c oxidase. Biochemistry 46:6239-48
Harman, Christine A; Turman, Melissa V; Kozak, Kevin R et al. (2007) Structural basis of enantioselective inhibition of cyclooxygenase-1 by S-alpha-substituted indomethacin ethanolamides. J Biol Chem 282:28096-105
Wada, Masayuki; DeLong, Cynthia J; Hong, Yu H et al. (2007) Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem 282:22254-66
Harman, Christine A; Rieke, Caroline Jill; Garavito, R Michael et al. (2004) Crystal structure of arachidonic acid bound to a mutant of prostaglandin endoperoxide H synthase-1 that forms predominantly 11-hydroperoxyeicosatetraenoic acid. J Biol Chem 279:42929-35
Garavito, R Michael; Mulichak, Anne M (2003) The structure of mammalian cyclooxygenases. Annu Rev Biophys Biomol Struct 32:183-206
Lin, Henry J; Lakkides, Karen M; Keku, Temitope O et al. (2002) Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia. Cancer Epidemiol Biomarkers Prev 11:1305-15
Garavito, R Michael; Malkowski, Michael G; DeWitt, David L (2002) The structures of prostaglandin endoperoxide H synthases-1 and -2. Prostaglandins Other Lipid Mediat 68-69:129-52
Garavito, R M; Ferguson-Miller, S (2001) Detergents as tools in membrane biochemistry. J Biol Chem 276:32403-6
Thuresson, E D; Lakkides, K M; Rieke, C J et al. (2001) Prostaglandin endoperoxide H synthase-1: the functions of cyclooxygenase active site residues in the binding, positioning, and oxygenation of arachidonic acid. J Biol Chem 276:10347-57
Thuresson, E D; Malkowski, M G; Lakkides, K M et al. (2001) Mutational and X-ray crystallographic analysis of the interaction of dihomo-gamma -linolenic acid with prostaglandin endoperoxide H synthases. J Biol Chem 276:10358-65

Showing the most recent 10 out of 16 publications